Can ketamine treatment for depression cause brain fog?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Ketamine Cause Brain Fog When Used for Depression?

Ketamine at therapeutic doses for depression does not cause brain fog and may actually improve cognitive function, particularly in processing speed and working memory. The FDA label warns about memory and attention impairment only with recurrent high-dose misuse or abuse, not therapeutic use 1.

Evidence from Therapeutic Use

The most robust evidence comes from systematic reviews and clinical trials examining cognitive effects in treatment-resistant depression:

  • A 2026 systematic review of ~900-1,180 TRD patients found no cognitive deterioration with IV ketamine treatment 2. Instead, procognitive effects were frequently observed in processing speed and working memory, with preserved or modestly improved attention.

  • A 2021 systematic review concluded that ketamine and esketamine do not exert significant deleterious neurocognitive effects in the short or long term in individuals with treatment-resistant depression 3. Five studies reported improvements in processing speed, verbal memory, visual memory, working memory, or cognitive flexibility.

  • A 2022 retrospective study of 22 TRD patients receiving 8-10 repeated ketamine infusions showed a 47.2% reduction in depression with no evidence of cognitive impairment on Montreal Cognitive Assessment testing 4.

Key Distinction: Therapeutic vs. Abuse Context

The FDA label makes a critical distinction 1:

  • Therapeutic doses (0.5 mg/kg IV): No cognitive impairment documented
  • Recurrent high-dose misuse/abuse: May be associated with memory and/or attention impairment

This is fundamentally different from the therapeutic context of depression treatment.

Mechanism of Cognitive Improvement

When cognitive improvements occur with ketamine treatment, they appear mediated by:

  • Reduction in depressive symptoms: A 2018 study using the Sobel test showed improvements in processing speed and verbal learning were significantly mediated by changes in depressive symptoms 5
  • Normalization of brain areas: Emotional and reward processing regions (amygdala, insula, orbitofrontal cortex) show normalizing tendencies after ketamine 3

Important Caveats

Long-term High-Dose Concerns

One 2025 preclinical study in rats found that long-term (but not short-term) ketamine administration impaired novel object recognition and increased stereotypic behaviors 6. However, this used 10 mg/kg in rats—substantially higher than human therapeutic protocols—and animal models don't directly translate to human therapeutic use.

Chronic Recreational Use

A 2024 study of chronic ketamine users (abuse context) found depressive symptoms contributed to cognitive impairments in memory and executive function 7. This is not applicable to supervised therapeutic use.

Clinical Recommendation

For patients with treatment-resistant depression receiving therapeutic ketamine (0.5 mg/kg IV), reassure them that brain fog is not an expected side effect. In fact, they may experience cognitive improvements, particularly if their depression improves. Monitor for:

  • Baseline cognitive function (better baseline visual learning predicts antidepressant response 5)
  • Improvements in processing speed and working memory as treatment progresses
  • Any acute dissociative symptoms during infusion (expected and transient)

Do not confuse the cognitive symptoms of depression itself (which can include subjective "brain fog") with ketamine effects. The evidence strongly suggests ketamine helps rather than harms cognition in this population.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.